Literature DB >> 8710362

G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4.

X Mayol1, J Garriga, X Graña.   

Abstract

During the transition from G1 to G0, p130 undergoes a specific phosphorylation event-leading to p130-form 2- that is mediated by a kinase/s other than the known G1, S and G2/M cyclin/CDKs. Changes in the phosphorylation status of p130 during this transition are responsible, at least in part, for the concomitant formation of p130/E2F-4 complexes, which are characteristic of G0. These complexes remain abundant during early G1 upon restimulation, but not after mitosis, and are dissociated in mid G1 when p130 is abruptly hyperphosphorylated to form 3. Subsequently, p130 forms 1 and 2 are no longer detected during the remainder of the cell cycle. Consistently, phosphorylation to form 3 and dissociation from E2F-4 complexes is reproduced by a cyclin/CDK holoenzyme in vitro. TGF-beta-induced G1 arrest abrogates cyclin/CDK phosphorylation of p130 but not phosphorylation to form 2. The cell cycle-dependent phosphorylation pattern of p130 is thus shown to comprise two distinct steps that are catalyzed by different kinases. The differential regulation of p130 and pRB phosphorylation during the transition from G1 to G0 may explain the fact that p130 and E2F-4 are the major components of E2F complexes in quiescent cells. Moreover, the newly described phosphorylation of p130 at the transition from G1 to G0 defines a novel mechanism of cell cycle exit regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710362

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 3.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

4.  The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.

Authors:  Lisa Osterloh; Björn von Eyss; Fabienne Schmit; Lena Rein; Denise Hübner; Birgit Samans; Stefanie Hauser; Stefan Gaubatz
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

5.  Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.

Authors:  Anton Chestukhin; Larisa Litovchick; Katherine Rudich; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

7.  c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Authors:  O W Prall; E M Rogan; E A Musgrove; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Close linkage of p130 and Ft1 is conserved among mammals.

Authors:  R Lesche; U Rüther
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

9.  Cyclin C regulates human hematopoietic stem/progenitor cell quiescence.

Authors:  Yasuhiko Miyata; Yan Liu; Vladimir Jankovic; Goro Sashida; Jennifer May Lee; Jae-Hung Shieh; Tomoki Naoe; Malcolm Moore; Stephen D Nimer
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

10.  CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2.

Authors:  Judit Garriga; Sabyasachi Bhattacharya; Joaquim Calbó; Renée M Marshall; May Truongcao; Dale S Haines; Xavier Graña
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.